Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]
News [7787]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
SABCS 2013: Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer
SABCS 2013: Bisphosphonate treatment fails to improve outcomes for women with chemoresistant breast cancer
SABCS 2013: New drug combo delayed disease progression for subgroup of women with metastatic breast cancer
SABCS 2013: New drug combo delayed disease progression for subgroup of women with metastatic breast cancer
SABCS 2013: Results from NeoALTTO trial indicate breast cancer patients who had pathologic complete response had improved survival
SABCS 2013: Results from NeoALTTO trial indicate breast cancer patients who had pathologic complete response had...
SABCS 2013: Study identifies highly effective treatment option for patients with HER2- positive breast cancer
SABCS 2013: Study identifies highly effective treatment option for patients with HER2- positive breast cancer
SABCS 2013: High levels of immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab
SABCS 2013: High levels of immune cells in tumours may identify breast cancer patients most likely to benefit from...
ASH 2013: Siltuximab shows efficacy for multicentric castleman’s disease
ASH 2013: Siltuximab shows efficacy for multicentric castleman’s disease
ASH 2013: IPI-145 may lend itself well to long-term therapy of patients with CLL
ASH 2013: IPI-145 may lend itself well to long-term therapy of patients with CLL
ASH 2013: Final stage II results of the CLL11 trial
ASH 2013: Final stage II results of the CLL11 trial
ASH 2013: Bcl-2 inhibitor ABT-199 monotherapy shows anti-tumour activity in high-risk chronic lymphocytic leukaemia and small lymphocytic lymphoma
ASH 2013: Bcl-2 inhibitor ABT-199 monotherapy shows anti-tumour activity in high-risk chronic lymphocytic...
ASH 2013: Phase III results of the FIRST trial (MM-020/IFM 07 01) in newly diagnosed multiple myeloma patients
ASH 2013: Phase III results of the FIRST trial (MM-020/IFM 07 01) in newly diagnosed multiple myeloma patients

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation